Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04504188 · ClinicalTrials.gov registry record · NA
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
A NA study of Heart Failure and Cardiomyopathies, sponsored by Zoll Medical Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 4
- Study locations
NCT04504188: Recruiting NA study of Heart Failure and Cardiomyopathies, sponsored by Zoll Medical Corporation.
NCT04504188 is a NA study of Heart Failure and Cardiomyopathies that is actively recruiting participants, run by Zoll Medical Corporation. The registered enrollment target is 300 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04504188, a NA study of Heart Failure and Cardiomyopathies, is actively recruiting participants, sponsored by Zoll Medical Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this pilot study is to document the percentage achievement in effective HR control (average nighttime HR \< 70 bpm) during WCD use in a cohort of female patients with cardiomyopathy in an outpatient setting using continuous heart rate (HR) trends data from the WCD to optimize BB/ivabradine dosage, as compared to a prior historical control.
Conditions Studied
Interventions
- DEVICE Heart Rate Monitor Enhanced Treatment Optimization
Study Locations (4)
Texas
- Texas Cardiology Associates of Houston - Kingwood
- CardioVoyage - McKinney
Ohio
- TriHealth Hatton Research Institute - Cincinnati
West Virginia
- CAMC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2024-12 |
| Phase | NA |
What NCT04504188 shows while recruiting
NCT04504188 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Heart Rate Monitor Enhanced Treatment Optimization is the first listed.
NCT04504188 reports a single indexed study location in Texas, Ohio, West Virginia.
Frequently Asked Questions
What is clinical trial NCT04504188 about?
NCT04504188 is a clinical study titled "Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator". The primary objective of this pilot study is to document the percentage achievement in effective HR control (average nighttime HR \< 70 bpm) during WCD use in a cohort of female patients with cardiomyopathy in an outpatient setting using continuous heart rate (HR) trends data from the WCD to optimiz...
What is the current status of trial NCT04504188?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2021-03-08. Estimated completion is 2024-12.
What conditions does trial NCT04504188 study?
This clinical trial studies the following conditions: Heart Failure, Cardiomyopathies.
What interventions are being tested in trial NCT04504188?
The interventions under investigation include: Heart Rate Monitor Enhanced Treatment Optimization (DEVICE).
Who is sponsoring clinical trial NCT04504188?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04504188 being conducted?
This trial has 4 study locations across Ohio, Texas, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04504188's enrollment target sits among peer trials
300 138th of 397 higher than 253 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI